These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2776165

  • 1. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 2. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A, Fareed J, Sabbá C, Albano O, Allegra C, Carlizza A, Binaghi F, Fronteddu F, Del Guercio R, Arpaia MR.
    Semin Thromb Hemost; 1991 Apr; 17 Suppl 2():228-34. PubMed ID: 1948094
    [Abstract] [Full Text] [Related]

  • 4. Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD).
    Craveri A, Tornaghi G, Ranieri R, Stanzani M, Landi G, Paganardi L, Passaretti B, Gallo E.
    Int Angiol; 1990 Apr; 9(4):274-7. PubMed ID: 2099963
    [Abstract] [Full Text] [Related]

  • 5. Defibrotide and peripheral obliterative arterial disease: preliminary data.
    Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, Lechi A.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):526-9. PubMed ID: 2533180
    [Abstract] [Full Text] [Related]

  • 6. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM, Sartori MT, Viero ML, Scapinello MP, Boeri G, Girolami A.
    Semin Thromb Hemost; 1991 Nov; 17 Suppl 1():101-5. PubMed ID: 2068562
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

  • 8. Use of defibrotide in the treatment of acute myocardial infarction.
    Milazzotto F, Carelli M, Citone C, Di Marcotullio G, Giampaolo P, Malinconico U, Polizzi C, Tubaro M, Giovannini E, Boccardi L.
    Semin Thromb Hemost; 1989 Oct; 15(4):464-9. PubMed ID: 2814516
    [Abstract] [Full Text] [Related]

  • 9. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease.
    Sabbá C, Zupo V, Dina F, Nazzari M, Albano O.
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):249-52. PubMed ID: 3045026
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].
    Michelini S, Micci A, Failla A, Grechi G, Iantaffi A.
    Minerva Cardioangiol; 1996 May; 44(1-2):33-7. PubMed ID: 8767620
    [Abstract] [Full Text] [Related]

  • 11. Effects of defibrotide on peripheral obliterative vascular diseases.
    Ulutin ON, Ilhan-Berkel N, Tunali H, Ozer M, Balkuv-Ulutin S, Onsel C, Urgancioğlu I.
    Haemostasis; 1986 May; 16 Suppl 1():59-62. PubMed ID: 3754837
    [Abstract] [Full Text] [Related]

  • 12. A new approach in the treatment of peripheral arterial occlusions: defibrination with arvin.
    Ehringer H, Dudczak R, Lechner K.
    Angiology; 1974 Apr; 25(4):279-89. PubMed ID: 4818725
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
    Mozzi E, Annoni F, Chiurazzi D, Rossi R, Pacini F, Martini A.
    Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499
    [No Abstract] [Full Text] [Related]

  • 14. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V.
    Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940
    [Abstract] [Full Text] [Related]

  • 15. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
    Cesaro S, Spiller M, Sartori MT, Alaggio R, Peruzzo M, Saggiorato G, Bisogno G.
    Pediatr Blood Cancer; 2011 Aug 25; 57(2):258-61. PubMed ID: 21246705
    [Abstract] [Full Text] [Related]

  • 16. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F, Marubini E, Coccheri S, Nenci GG.
    Thromb Haemost; 2000 May 25; 83(5):672-7. PubMed ID: 10823260
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of short-term defibrotide treatment of patients with atherosclerosis obliterans of the lower limbs.
    Avellone G, Mandalà V, Pinto A, Martino A, Strano A.
    Haemostasis; 1986 May 25; 16 Suppl 1():55-8. PubMed ID: 2423422
    [Abstract] [Full Text] [Related]

  • 18. Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease.
    Di Perri T, Forconi S, Guerrini M, Pasini FL, Del Cippola R, Rossi C, Angnusdei D.
    Angiology; 1979 Jan 25; 30(1):13-20. PubMed ID: 426317
    [Abstract] [Full Text] [Related]

  • 19. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 25; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

  • 20. The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease.
    Di Perri T, Forconi S, Agnusdei D, Guerrini M, Laghi Pasini F.
    Br J Clin Pharmacol; 1978 Mar 25; 5(3):255-60. PubMed ID: 656271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.